最近搜索:細胞培養(yǎng) 微生物學(xué) 分子生物 生物化學(xué)
    首頁>>免疫學(xué)>>一抗>>維甲酸受體RAR α/RAR α抗體
    維甲酸受體RAR α/RAR α抗體
    • 產(chǎn)品貨號:
      BN40721R
    • 中文名稱:
      維甲酸受體RAR α/RAR α抗體
    • 英文名稱:
      Rabbit anti-RAR alpha Polyclonal antibody
    • 品牌:
      Biorigin
    • 貨號

      產(chǎn)品規(guī)格

      售價

      備注

    • BN40721R-100ul

      100ul

      ¥2360.00

      交叉反應(yīng):Human(predicted:Mouse,Rat,Chicken,Dog,Pig,Cow,Horse,Rabbit,Sheep) 推薦應(yīng)用:WB

    • BN40721R-200ul

      200ul

      ¥3490.00

      交叉反應(yīng):Human(predicted:Mouse,Rat,Chicken,Dog,Pig,Cow,Horse,Rabbit,Sheep) 推薦應(yīng)用:WB

    產(chǎn)品描述

    英文名稱RAR alpha
    中文名稱維甲酸受體RAR α/RAR α抗體
    別    名Acute Promelocytic Leukemia Breakpoint Cluster Region; Acute Promelocytic Leukemia Breakpoint Cluster Region; NR1B1; Nuclear mitotic apparatus protein retinoic acid receptor alpha fusion protein; Nuclear receptor subfamily 1 group B member 1; Nucleophosmin retinoic acid receptor alpha fusion protein NPM RAR long form; RAR A; RAR alpha; RAR alpha; RAR alpha form; RAR alpha form; RAR; RAR-alpha; RARA; RARA; RARA protein; RARA/PML Fusion Gene; RARA/PML Fusion Gene; RARA_HUMAN; RARalpha; RARalpha1; Retinoic acid receptor alpha; Retinoic acid receptor alpha polypeptide  
    研究領(lǐng)域腫瘤  細胞生物  免疫學(xué)  神經(jīng)生物學(xué)  信號轉(zhuǎn)導(dǎo)  細胞凋亡  激酶和磷酸酶  
    抗體來源Rabbit
    克隆類型Polyclonal
    交叉反應(yīng)Human,  (predicted: Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Sheep, )
    產(chǎn)品應(yīng)用WB=1:500-2000 
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
    分 子 量51kDa
    細胞定位細胞核 細胞漿 
    性    狀Liquid
    濃    度1mg/ml
    免 疫 原KLH conjugated synthetic peptide derived from human RAR alpha:161-260/462 
    亞    型IgG
    純化方法affinity purified by Protein A
    儲 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
    保存條件Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
    PubMedPubMed
    產(chǎn)品介紹Acute Promelocytic Leukemia Breakpoint Cluster Region; Acute Promelocytic Leukemia Breakpoint Cluster Region; NR1B1; Nuclear mitotic apparatus protein retinoic acid receptor alpha fusion protein; Nuclear receptor subfamily 1 group B member 1; Nucleophosmin retinoic acid receptor alpha fusion protein NPM RAR long form; RAR A; RAR alpha; RAR alpha; RAR alpha form; RAR alpha form; RAR; RAR-alpha; RARA; RARA; RARA protein; RARA/PML Fusion Gene; RARA/PML Fusion Gene; RARA_HUMAN; RARalpha; RARalpha1; Retinoic acid receptor alpha; Retinoic acid receptor alpha polypeptide

    Function:
    Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RXR/RAR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone acetylation, chromatin condensation and transcriptional suppression. On ligand binding, the corepressors dissociate from the receptors and associate with the coactivators leading to transcriptional activation. RARA plays an essential role in the regulation of retinoic acid-induced germ cell development during spermatogenesis. Has a role in the survival of early spermatocytes at the beginning prophase of meiosis. In Sertoli cells, may promote the survival and development of early meiotic prophase spermatocytes. In concert with RARG, required for skeletal growth, matrix homeostasis and growth plate function (By similarity). Regulates expression of target genes in a ligand-dependent manner by recruiting chromatin complexes containing MLL5. Mediates retinoic acid-induced granulopoiesis.

    Subunit:
    Heterodimer; with RXRA. Binds DNA preferentially as a heterodimer. Interacts with CDK7 By similarity. Interacts with coactivators NCOA3 and NCOA6. Interacts with NCOA7; the interaction requires ligand-binding. Interacts with MLL5. Interacts (via the ligand-binding domain) with PRAME; the interaction is ligand (retinoic acid)-dependent. Interacts with AKT1; the interaction phosphorylates RARA and represses transactivation. Interacts with PRKAR1A; the interaction negatively regulates RARA transcriptional activity. Interacts with NCOR1 and NCOR2. Interacts with PRMT2. Interacts with LRIF1. Interacts with ASXL1 and NCOA1.

    Subcellular Location:
    Nucleus. Cytoplasm. Nuclear localization depends on ligand binding, phosphorylation and sumoylation. Transloaction to the nucleus in the absence of ligand is dependent on activation of PKC and the downstream MAPK phosphorylation.

    Post-translational modifications:
    Phosphorylated on serine and threonine residues. Phosphorylation does not change during cell cycle. Phosphorylation on Ser-77 is crucial for transcriptional activity. Phosphorylation by AKT1 is required for the repressor activity but has no effect on DNA binding, protein stability nor subcellular localization. Phosphorylated by PKA in vitro. This phosphorylation on Ser-219 and Ser-369 is critical for ligand binding, nuclear localization and transcriptional activity in response to FSH signaling.
    Sumoylated with SUMO2, mainly on Lys-399 which is also required for SENP6 binding. On all-trans retinoic acid (ATRA) binding, a confromational change may occur that allows sumoylation on two additional site, Lys-166 and Lys-171. Probably desumoylated by SENP6. Sumoylation levels determine nuclear localization and regulate ATRA-mediated transcriptional activity.
    Trimethylation enhances heterodimerization with RXRA and positively modulates the transcriptional activation.
    Ubiquitinated.

    DISEASE:
    Chromosomal aberrations involving RARA are commonly found in acute promyelocytic leukemia. Translocation t(11;17)(q32;q21) with ZBTB16/PLZF; translocation t(15;17)(q21;q21) with PML; translocation t(5;17)(q32;q11) with NPM. The PML-RARA oncoprotein requires both the PML ring structure and coiled-coil domain for both interaction with UBE2I, nuclear microspeckle location and sumoylation. In addition, the coiled-coil domain functions in blocking RA-mediated transactivation and cell differentiation.

    Similarity:
    Belongs to the nuclear hormone receptor family. NR1 subfamily.
    Contains 1 nuclear receptor DNA-binding domain.

    SWISS:
    P11416

    Gene ID:
    5914

    Database links:

    Entrez Gene: 5914 Human

    Entrez Gene: 19401 Mouse

    Entrez Gene: 24705 Rat

    Omim: 180240 Human

    SwissProt: P10276 Human

    SwissProt: P11416 Mouse

    Unigene: 654583 Human

    Unigene: 439744 Mouse

    Unigene: 91057 Rat



    Important Note:
    This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

    類固醇受體(Steroid Receptors) RAR-α在人組織細胞分化過程中具有重要作用,尤其在腫瘤分化的特殊階段起到一定的作用,在造血細胞中,RARα表達豐富。





































    image.png

    国产亚洲色视频在线| 亚洲视频在线观看免费视频| 久久精品国产精品亚洲色婷婷| 亚洲成?v人片天堂网无码| 亚洲精品美女久久7777777| 亚洲第一区二区快射影院| 亚洲国产成人在线视频| 亚洲国产精品免费在线观看| 亚洲邪恶天堂影院在线观看| 亚洲午夜精品久久久久久人妖| 亚洲视频精品在线| 亚洲毛片一级带毛片基地| 亚洲精品国产福利在线观看| 亚洲国产韩国一区二区| 精品亚洲AV无码一区二区| 亚洲一日韩欧美中文字幕在线| 亚洲一卡一卡二新区无人区| 亚洲欧美乱色情图片| 亚洲av成人一区二区三区在线播放| 国产亚洲视频在线播放大全| 亚洲A丁香五香天堂网| 国产a v无码专区亚洲av| 亚洲人成色777777在线观看| 国产亚洲综合网曝门系列| 亚洲av不卡一区二区三区| 亚洲精品第五页中文字幕| 亚洲av无码久久忘忧草| 亚洲午夜无码久久| 另类专区另类专区亚洲| 美腿丝袜亚洲综合| 久久久久亚洲AV成人无码| 亚洲视频免费在线播放| 久久国产亚洲精品| 理论亚洲区美一区二区三区| 国产精品亚洲w码日韩中文| 亚洲av永久无码精品漫画| 亚洲精品午夜视频| 亚洲中文字幕乱码AV波多JI| yy6080久久亚洲精品| 精品久久久久久亚洲| 亚洲成人福利在线|